Clinical Trial Detail

NCT ID NCT03832569
Title Study of Pembrolizumab or Placebo Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Advanced Solid Tumor

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.